HIV: AIDS virus on the attack
Key points
- The AIDS virus, HIV-1, produces Vif (virion infectivity factor) protein during the late stages of infection.
- Sheehy et al. have now identified a human gene, CEM15, as the cellular target of Vif.
- Vif seems to inhibit an innate antiviral activity expressed in human T lymphocytes.
- Molecules that render the T-cell enzyme 'Vif-proof', or interfere with Vif's inhibitory function, could make ideal candidates for new anti-HIV drugs.
The AIDS virus, HIV-1, produces Vif (virion infectivity factor) protein during the late stages of infection. Vif seems to inhibit an innate antiviral activity expressed in human T lymphocytes.
Sheehy et al. have now identified a human gene, CEM15, as the cellular target of Vif. Molecules that render the T-cell enzyme 'Vif-proof', or interfere with Vif's inhibitory function, could make ideal candidates for new anti-HIV drugs. On the cover, immunofluorescent staining of an HIV-1-infected human macrophage with Vif in green.

Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Infections, HIV & STIs →
NewsAIDS treatment benefits health, economics of people without HIV, study shows
In rural Malawi, roughly 10 percent of the adult population has HIV. At the peak of the epidemic, in the 1990s and early 2000s, nearly everyone knew someone infected with or affected by the virus, what demographer…
12 December 2015
NewsHIV discovery - biomarkers predict virus return when treatment is stopped
Scientists are now better able to predict how quickly the HIV virus will return after individuals stop treatment following a discovery by researchers at UNSW Australia and the University of Oxford. The significant…
10 October 2015
NewsTargeting HIV in semen to shut down AIDS
There may be two new ways to fight AIDS - using a heat shock protein or a small molecule - to attack fibrils in semen associated with the human immunodeficiency virus (HIV) during the initial phases of infection,…
19 August 2015





